📑Generic Drugs -- Tablets and Capsules.
Procurement process summary
This process is to purchase Generic Drugs -- Tablets and Capsules.
This contract was awarded by 🇪🇺 ABM University Health Board for an amount of GBP 10,832,796 to 1 supplier. It was published on 2015-03-21 through open
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇪🇺 ABM University Health Board Buying unitnot reported Publication date2015-03-21 Contest statusnot reported DescriptionGeneric Drugs -- Tablets and Capsules.Awards
This award was granted to Relonchem Ltd by ABM University Health Board for an amount of GBP 10,832,796. The procurement process was conducted through open for the category of goods. This is award number 30.
This contract has multiple awards. This is award number 30. View other awards for this contract
| Supplier | Amount | Award number |
|---|---|---|
| 🇬🇧 Relonchem Ltd | GBP 10,832,796 | 30 |
Market context and opportunities
The execution of this contract allows the entity ABM University Health Board to fulfill its public service objectives efficiently.
The open purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberEU_ocds-70d2nz-4a8ee2fc-9184-4925-a683-ad3e3bed261f-award-30Publication date2015-03-21Contract datenot reportedAward datenot reportedCategoriesgoodsPurchase modalityopenMethod detailspt_openStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
